Neuropace Inc (NPCE) — SC 13G/A Filings
All SC 13G/A filings from Neuropace Inc. Browse 8 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (8)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Oct 3, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
FMR LLC & Abigail Johnson Trim NeuroPace Stake to 1.78%
— Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership in NeuroPace Inc. (NRPCE) through an SC 13G/A filing -
Morgan Stanley Amends NeuroPace (NPCE) Stake Disclosure
— Feb 9, 2024 Risk: low
Morgan Stanley filed an amended SC 13G/A on February 9, 2024, indicating a change in its beneficial ownership of NeuroPace Inc. common stock as of December 31, -
Soleus Private Equity Amends NeuroPace Stake (SC 13G/A)
— Feb 2, 2024
Soleus Private Equity Fund I, L.P. filed an Amendment No. 3 to Schedule 13G on February 2, 2024, indicating a change in their ownership of NeuroPace Inc. (CUSIP
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX